InvestSMART

Medlab Clinical Limited (ASX: MDC) - Announcements

DELISTED - Current share price for MDC : $6.600

ASX company news and announcements for Medlab Clinical Limited (MDC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Medlab Clinical Limited (MDC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Medlab Clinical Limited (MDC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Medlab Clinical Limited (MDC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 4C - quarterly 30 Jul 2020 10:08AM $0.135 $6.600 risen by 4,788.89%
- Section 708A Cleansing Notice 9 Jul 2020 4:01PM $0.150 $6.600 risen by 4,300%
- Appendix 2A 8 Jul 2020 2:52PM $0.153 $6.600 risen by 4,227.87%
- Completion of SPP 8 Jul 2020 2:42PM $0.150 $6.600 risen by 4,300%
- Invitation to Virtual Research Symposium 7 Jul 2020 12:04PM $0.155 $6.600 risen by 4,158.06%
- Lapse of Unlisted Options 1 Jul 2020 3:29PM $0.150 $6.600 risen by 4,300%
- Medlab Completes First Order of New Cannabinoid to UK 29 Jun 2020 9:16AM $0.140 $6.600 risen by 4,614.29%
- Reminder - Medlab Shareholder Video Conference 26 Jun 2020 3:19PM $0.140 $6.600 risen by 4,614.29%
- Change in substantial holding x 3 22 Jun 2020 2:31PM $0.150 $6.600 risen by 4,300%
- Section 708A Cleansing Notice 22 Jun 2020 2:07PM $0.150 $6.600 risen by 4,300%
- Appendix 2A 18 Jun 2020 11:20AM $0.160 $6.600 risen by 4,025%
- Share Purchase Plan and Invitation to Shareholder Update 17 Jun 2020 9:10AM $0.155 $6.600 risen by 4,158.06%
- Section 708A Cleansing Notice 16 Jun 2020 11:31AM $0.165 $6.600 risen by 3,900%
- Proposed issue of Securities - MDC 15 Jun 2020 9:44AM $0.205 $6.600 risen by 3,119.51%
- Medlab Completes Successful $5.4m Placement 15 Jun 2020 9:36AM $0.205 $6.600 risen by 3,119.51%
- NanoCBD Delivery Received and First Patient Supplied 11 Jun 2020 9:54AM $0.205 $6.600 risen by 3,119.51%
- Company Update 11 Jun 2020 9:34AM $0.205 $6.600 risen by 3,119.51%
- Trading Halt 11 Jun 2020 8:52AM $0.205 $6.600 risen by 3,119.51%
- First Batches of NanaBis Delivered from Tasmanain Alkaloids 3 Jun 2020 9:27AM $0.205 $6.600 risen by 3,119.51%
- Clarification to Appendix 4C 19 May 2020 2:33PM $0.215 $6.600 risen by 2,969.77%
- Appendix 4C - quarterly 27 Apr 2020 12:40PM $0.230 $6.600 risen by 2,769.57%
- MDC Extends NanoCelle Platform to Anti-Malaria Drug 21 Apr 2020 10:00AM $0.220 $6.600 risen by 2,900%
- Trading Halt 17 Apr 2020 3:18PM $0.220 $6.600 risen by 2,900%
- Pause in Trading 17 Apr 2020 10:38AM $0.210 $6.600 risen by 3,042.86%
- Change of Director's Interest Notice 15 Apr 2020 2:51PM $0.230 $6.600 risen by 2,769.57%

201 - 225 of 435 results

Page 9 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.